In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Shines Light on Vulnerable Plaque with Miravant Deal

Executive Summary

Guidant appears to be the leader among the large cardiovascular device companies in pursuing device-based therapies for vulnerable plaque. The company's latest move in this space is a collaboration with Miravant Medical Technologies regarding using photodynamic therapy as a possible treatment for vulnerable plaque lesions.
Advertisement

Related Content

How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook
Biosensors: Small Company Turns Major Dealmaker
TopSpin Medical Inc.
Guidant: The New Rules of the Device Game
Guidant's Loss of Innocence
Vulnerable Plaque: Medical Device's New Biological Frontier
Vulnerable Plaque Heats Up
The Unstable State of Plaque Detection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel